173 related articles for article (PubMed ID: 29753699)
1. Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura.
Gurlek Gokcebay D; Guzelkucuk Z; Yarali N
Transfus Apher Sci; 2018 Jun; 57(3):416-417. PubMed ID: 29753699
[No Abstract] [Full Text] [Related]
2. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.
Mantadakis E; Danilatou V; Stiakaki E; Kalmanti M
Am J Hematol; 2004 Nov; 77(3):303-10. PubMed ID: 15495242
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
5. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of Evans syndrome with Tacrolimus.
Tabchi S; Hanna C; Kourie HR; Aftimos P; El Osta L; Ghosn M
Invest New Drugs; 2015 Feb; 33(1):254-6. PubMed ID: 25209619
[No Abstract] [Full Text] [Related]
7. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
8. [Anemia and hemorrhagic diathesis in autoimmune hemolysis and immune thrombocytopenia].
Stemmler HJ; Ochmann O; Pihusch R; Hiller E
Internist (Berl); 1996 Jan; 37(1):78-81. PubMed ID: 8837831
[No Abstract] [Full Text] [Related]
9. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
Aleem A
Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
[No Abstract] [Full Text] [Related]
10. Infection risk in autoimmune hematological disorders with low-dose rituximab treatment.
Wang H; Yan S; Liu H; Li L; Song J; Wang G; Wang H; Wu Y; Shao Z; Fu R
J Clin Lab Anal; 2020 Oct; 34(10):e23455. PubMed ID: 32794271
[TBL] [Abstract][Full Text] [Related]
11. Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.
Westermann-Clark E; Meehan CA; Meyer AK; Dasso JF; Amre D; Ellison M; Patel B; Betensky M; Hauk CI; Mayer J; Metts J; Leiding JW; Sriaroon P; Kumar A; Ayala I; Walter JE
Front Immunol; 2021; 12():649182. PubMed ID: 33968040
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.
Li H; Ji J; Du Y; Huang Y; Gu H; Chen M; Wu R; Han B
Exp Hematol; 2020 Sep; 89():87-95. PubMed ID: 32771553
[TBL] [Abstract][Full Text] [Related]
13. Maintenence rituximab following induction in autoimmune cytopenias.
Rai MP; Lee EJ; Bussel JB
Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
[TBL] [Abstract][Full Text] [Related]
14. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
15. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib for immune thrombocytopenia and autoimmune hemolytic anemia.
Muhsen IN; Alahmari A; Alnahedh M; Alkhudair NA; Samarkandi H; El Fakih R
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):251-254. PubMed ID: 31202670
[No Abstract] [Full Text] [Related]
17. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
18. Expanded utilization of rituximab in paediatric cardiac transplant patients.
Kiskaddon AL; Landmesser K; Carapellucci J; Wisotzkey B; Asante-Korang A
J Clin Pharm Ther; 2021 Jun; 46(3):762-766. PubMed ID: 33393702
[TBL] [Abstract][Full Text] [Related]
19. Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review.
Kim TO; Grimes AB; Kirk S; Arulselvan A; Lambert MP; Grace RF; Despotovic JM
Am J Hematol; 2019 Apr; 94(4):461-466. PubMed ID: 30663792
[TBL] [Abstract][Full Text] [Related]
20. ITP Is Neither Idiopathic nor Always Benign.
Konda M; Fletcher M; Warrier R
Clin Pediatr (Phila); 2021 Mar; 60(3):193-194. PubMed ID: 33305594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
